The New EPICO3 Manufacturing Facility on-track for operation in 2024
August 21st, 2023
The media office of the Suez Canal Economic Zone announced, in a statement issued on Monday August 14, 2023, that Al Adabiya port of the Economic Zone had received the heavyweight ship (DA QING XIA), coming from China, to unload 136 parcels and containers weighing 2,630 tons, including units of concrete structures for a modular turn-key facility built by the Swedish company Pharmadule Morimatsu, in favor the Egyptian International Pharmaceutical Industries (EIPICO) for its new manufacturing facility EPICO 3 Factory. Shortly after, EIPICO fulfilled the customs requirements, and the Modules were released & transported to the EIPICO 3 site.
The EIPICO 3 facility will be the first and largest factory in Egypt and the Middle East to produce biologicals and biosimilars alternatives and medicines in the 10th of Ramadan City with an area of 10.000 sqm. EIPICO 3 will manufacture biological products, monoclonal antibodies (mAbs) and biopharmaceutical proteins. The actual implementation of the project is planned for operation by the end of the second quarter of 2024, with investments amounting to $100 million.